The Cord Blood Transplantation: A Life Savior Technique
The cord Blood which was discarded soon after the birth of a baby is regarded as a life saving device for the future generations of a family. It has thereby become imperative to save this cord blood which is rich in stem cells necessary for the treatment of several life threatening diseases. During last ten years, over 4000 umbilical cord blood transplantations have been performed worldwide. The interest in this mode of transplantation has been growing drastically, as this provides easy access to an alternative for treating cancer and serious genetic disorders.
If you have been told a bone marrow transplant (BMT) is a possible treatment for your disease, a cord blood transplant may be an option. Umbilical cord blood is one of three sources for the blood-forming cells used in transplants. The other two sources are bone marrow and peripheral (circulating) blood. The first cord blood transplant was done in 1988. Cord blood plays an important role in transplant today. Doctors are still learning about the ways cord blood transplants are similar to and different from marrow or peripheral blood transplants.
Umbilical cord blood is collected from the umbilical cord and placenta after a baby is born. This blood is rich in stem cells. The donated cord blood is tested, frozen and stored at a cord blood bank for future use. The stored cord blood is called a cord blood unit (cbu).
The National Marrow Donor Program (NMDP) registry includes more than 70,000 cbu. Doctors search the NMDP Registry of adult marrow or peripheral blood cell donors and cord blood units to find a suitable HLA match for their patients who need a transplant. If selected, the matching blood is transplanted to a patient. The transplant process is the same as for marrow and peripheral blood cell transplants
The use of cord blood transplants has grown for both children and adults. It is used more often in children because an umbilical cord holds a limited amount of blood. The number of blood-forming cells in a transplant needs to match the size of the patient — smaller patients need fewer cells and larger patients need more cells. Some cord blood units may not have enough blood-forming cells for some patients.
Doctors are trying different ways to increase the number of cells in a cbu so they can use cord blood for larger patients. One method being studied is to give a patient two cord blood units. Another method being studied is to grow the number of cells in a in a laboratory before giving it to the patient.
When your doctor searches the NMDP Registry, he or she will choose the best cell source for you. That may be marrow or peripheral blood from an adult donor or it may be a cord blood unit. A doctor might choose cord blood because of some of the ways it differs from marrow or peripheral blood.
A close match between the patient and the donor or cord blood unit can improve a patient's outcome after transplant. Even though a closely matched one is always preferred, clinical studies suggest the match may not have to be as close as is needed for marrow or peripheral blood transplants. If you have an uncommon tissue type, your doctor may not find a closely matched adult donor for you. However, a cord blood unit may be an option.
Cord blood units are stored and ready to use. It can take two months or more to find an unrelated marrow or peripheral blood donor. A unit can be selected and delivered to the transplant center in less than two weeks. Your doctor may choose cord blood if you need a transplant quickly.
Graft-versus-host disease (GVHD) is a common complication after an allogeneic transplant (which uses cells from a family member, unrelated donor or cord blood unit). GVHD can range from mild to life-threatening. Studies have found that after a transplant, fewer patients get GVHD than after marrow or peripheral blood transplants.
However there are chances that your doctor might not approve of Cord blood transplantation. The possible reasons for this are:
• There may not be enough blood-forming cells in a cord blood unit for the size of the patient.
• It usually takes longer for cord blood cells to engraft (begin to grow and create new blood cells and an immune system). Until the cells engraft, the patient is at a high risk for infection.
• Patients cannot get backup cells from the same cord blood unit. If a patient's transplanted marrow or peripheral blood cells do not engraft or the patient relapses, the patient may be able to get a second donation from the same adult donor. After a cord blood transplant, this option is not available. However, doctors may be able to use a different cord blood unit or a backup adult donor instead.
• Cord blood is a newer treatment approach for transplant. Doctors do not have as much information about patients' long-term results after cord blood transplants as they do for marrow transplants.
Cord blood transplants also have all the same risks as marrow and peripheral blood transplants. The risk of infection may be higher after a cord blood transplant because of the longer time to engraft. The risk of GVHD may be lower, but the risk is still there.
If you have questions about whether a cord blood transplant is right for you, talk with your doctor. Every patient's situation is different. Your transplant doctor knows your situation and can help you make choices about your treatment.
